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In the Department of Respiratory Medicine, North Staffordshire Hospital, patients fulfilling the Department of 
Health criteria for long-term oxygen therapy (LTOT) attend a practical teaching session on the use of their oxygen 
concentrator before commencing therapy. In the present study, we have audited the prescribing of LTOT in all 
patients in three health districts in the North West Midlands reviewed between June 1992 and July 1994. They were 
split into two groups. The first had the assessment and training programme in the department. Patients in the control 
group had been prescribed LTOT from outside the department without any formal training. In both groups of 
patients information was collated 6 months after starting LTOT by means of a questionnaire assessing patients’, 
understanding of both their need for oxygen and their disease process, the dangers of oxygen therapy and present 
smoking habit. Objective information about the usage of each concentrator was obtained from engineer reports. 
Thirty-six patients (eight from the trained group and 28 controls) died before evaluation at 6 months. Forty-five 
patients (29 male, mean age 71 years) received training and 41 control patients (24 male, mean age 72 years) were 
evaluated. Thirty-seven (82%) patients who had received formal training were using their concentrator for greater 
than 15 h compared with only 18 (44%) of the controls (P=O.O002). Forty-two (93%) patients who had received 
training understood why they were using LTOT compared with only 17 (41%) in the control group (P=O.OOOOl). 
Although both groups had a similar understanding of the dangers of smoking while on oxygen therapy, six (15%) 
of the control group were smoking as compared to only one (2%) of the trained group (P=O.O38). One of the control 
patients had received significant facial burns as a direct result of smoking while on oxygen. Further efforts are 
required to ensure that all patients prescribed LTOT should have a formal respiratory assessment as well as training 
to improve compliance and to obtain maximal benefits from such therapy. 
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Introduction 
The oxygen concentrator is the most practical and cost- 
effective method of delivering long-term oxygen therapy 
(LTOT) in the U.K. to hypoxic patients with chronic 
obstructive pulmonary disease (1,21). However, the initial 
cost of LTOT therapy remains high. In an attempt to 
improve appropriate prescribing in the North Staffordshire 
district, the Department of Health guidelines (3) were 
programmed into the departmental computer system and 
the issuing of oxygen concentrators with the agreement of 
the general practitioner was devolved to the respiratory 
technicians and nurses, following an initial medical review 
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by the chest consultants. Since 1991, patients recommended 
for LTOT through such an assessment procedure attend a 
practical teaching session run by the respiratory care 
nurses. Emphasis is placed on the importance of using 
oxygen for at least 15 h every day. 
In the present study we report on an audit carried out to 
assess LTOT prescribing practice in our region and to 
assess the effectiveness of our assessment and training 
programme. 
Patients 
All patients in three health districts in the North West 
Midlands prescribed LTOT between June 1992 and July 
1994 were recruited. The assessment group included all 
patients having the assessment and training programme in 
The Department of Respiratory Medicine. They were 
shown to have stable hypoxia with a PaO, of 17.3 kPa and 
stable spirometry on two separate occasions at least 3 weeks 
0 1998 W. B. SAUNDERS COMPANY LTD 
1204 D. G. PECKHAM ET AL 
apart. Controlled oxygen administration was required to 
increase the PaO, to >8 kPa without an accompanied rise 
in PaCO, of more than 1 1cPa. Spirometry and carboxy- 
haemoglobin to check if currently smoking were each 
formally recorded on both occasions. Each individual 
received a 1 h training session by the respiratory care nurses 
at the onset of treatment. The need to use oxygen for at 
least 15 out of 24 h was explained and emphasized. The 
dangers involved in using oxygen were stressed with a 
further check that patients were not currently smoking. 
Each patient was shown an oxygen concentrator, and the 
controls, alarm system and engineering back-up services 
explained. The control group consisted of all other patients 
in the study area who had been prescribed an oxygen 
concentrator between June 1992 and July 1994. The oxygen 
had been prescribed by a general practitioner often without 
assessment. If a respiratory department was involved, the 
physician was contacted to confirm no formal training had 
been given. 
Methods 
Electrical meter recordings from the concentrator of each 
patient were supplied by De Vilbiss Healthcare (Middlesex, 
U.K.). The primary outcome measure, the average reading 
for each 24 h for the 6 months, was calculated. 
All patients answered a questionnaire administered by a 
single researcher, 6 months after having starting LTOT. 
The questionnaire assessed their understanding of both 
their need for oxygen and their disease process, the dangers 
of oxygen therapy, present smoking habit and the daily 
duration of LTOT. To the question: ‘do you know why you 
need oxygen? any response indicating a lack of oxygen in 
the blood or body was taken as correct. To the question: 
‘what would you do if an alarm sounded?‘, a more informa- 
tive answer than switch off and ring the engineer was 
needed. For example, checking for a pipe or filters blockage 
would be a correct response. Patients who were regarded as 
having some knowledge of the dangers of oxygen needed to 
mention the avoidance of fire, sparks or smoking. 
DATA ANALYSIS 
Because the data was not normally distributed the results 
were expressed as medians and ranges. The Mann-Whitney 
U test was used for analysing unpaired data. The Fisher 
exact test was used when comparing differences between 
subgroups of the two samples. A P value CO.05 was 
regarded as statistically significant. 
Results 
Fifty-three patients receiving training and 69 controls 
entered the study prospectively. However, 36 patients (eight 
trained and 28 controls) died before evaluation at 6 months. 
Forty-five patients [29 males, mean age 71 (51-83) years] 
receiving the assessment and training programme and 41 
controls [24 males, mean age 72 (60-89 years)] were evalu- 
ated. There was no significant difference in patient age 
between both groups. Lung function and blood gases were 
only available for 21 (51%) patients in the control group 
(eight of the 21 did not meet the guidelines); the remainder 
of patients not receiving any form of assessment prior to 
starting LTOT. Clinical details are outlined in Table 1. 
Thirty-seven (82%) patients who had received formal 
training were using their oxygen concentrator according to 
their meter readings for at least 15 out of 24 h compared 
with only 1X (44%) of the controls (P<O.O002). These 
objective measurements of oxygen usage were in broad 
agreement with the replies on usage of LTOT on the 
questionnaire (r=0.56, P<O.OOl). Forty-two (93%) patients 
who had received training understood why they were using 
LTOT as compared to only 17 (41%) in the control group 
(P~O.00001). Although both groups had a similar under- 
standing of the dangers of smoking while on oxygen 
therapy, six (15%) of the controls were smoking as com- 
pared to only one (2%) of the trained group (P~O.038). One 
of the control patients had received significant facial burns 
as a direct result of smoking while on oxygen. 
In the control group, there was no significant statistical 
difference in meter readings between the 21 patients who 
had undergone an initial assessment and the 20 patients 
who had not. Only eight patients in the former group were 
using oxygen for greater than 15 h as compared to 10 in the 
latter group. There was no significant difference in retention 
of information between either sex. 
Discussion 
The oxygen concentrator is a convenient and effective 
method for delivering a continuous supply of domiciliary 
oxygen in patients who fulfil the Department of Health 
criteria for long-term oxygen use (3). Treatment of 
hypoxaemia with LTOT is aimed at improving both 
respiratory and cardiac function and can result in sig- 
nificant clinical benefits such as improvement in exercise 
tolerance and general well being (1,2,4,5). For maximal 
benefits to be obtained, oxygen therapy should be used for 
as many hours per day as possible (minimum of 15 h daily), 
as past studies have demonstrated a correlation between the 
duration of therapy and reduced patient mortality. One of 
the earliest studies to investigate this correlation was the 
NOTT study (6) which demonstrated a significant reduc- 
tion in mortality in those patients receiving oxygen for 19 h 
as compared with nocturnal therapy alone. These findings 
were in broad agreement with the MRC trial (7) which 
demonstrated a two-fold increase in mortality among con- 
trol patients not receiving LTOT in contrast to patients 
receiving 15 h oxygen therapy a day. There is evidence that 
the prescribing of LTOT to COPD patients with moderate 
hypoxaemia (PaO, >7.4 kPa) has no effect on prolonging 
patient survival (8). 
In the U.K., patients should only be prescribed an 
oxygen concentrator following a formal assessment in 
accordance with the Department of Health guidelines 
which state that the PaO, should be less than 7.3 kPa. 
Despite the introduction of such guidelines, several studies 
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TABLE 1. Clinical details. Only 21 control patients received assessment prior to starting LTOT 
Patients receiving teaching Controls 
n=45 n=41 
Diagnosis 
Median (range) FEV, (1) 
Median (range) FVC (1) 
Median (range) PaO, (kPa) 
Median (range) PaCO, (kPa) 
COPD n=37 
Lung fibrosis n =4 
Pneumoconiosis n = 2 
Sarcoidosis n = 1 
Bronchiectasis n = 1 
0.71 (0.24-2.6) 
1.88 (0.64427) 
6.48 (3.8-7.38) 
5.87 (3.58-853) 
COPD n=38 
Lung fibrosis n =2 
TB n=l 
0.85 (0.4-1.47) 
n=21 
1.52 (0.79-3.91) 
n=21 
7.2 (5.5-9.43) 
n=21 
5.6 (4.3-8.3) 
n=21 
COPD, Chronic obstructive pulmonary disease; TB, tuberculosis. 
have demonstrated that the prescribing of LTOT can often 
be inappropriate. In Merseyside (9), fewer than a third of 
concentrators were found to have been supplied appropri- 
ately. In Sheffield (10) only 43% of patients met the full 
DHSS criteria for LTOT before treatment was instituted. In 
Avon (11) 37% of patients had not received an oxygen 
concentrator according to the Department of Health guide- 
lines. The appropriateness of such therapy was significantly 
increased if the prescribing doctor was a respiratory physi- 
cian. Despite the introduction of guidelines and widely 
published data demonstrating the importance of a formal 
respiratory assessment prior to LTOT, we found that a 
significant proportion of patients in our study population 
still have little or no assessment. In the control group eight 
out of 21 patients formally assessed did not fully obey the 
criteria while 20 had no assessment at all. 
Coupled with the appropriateness of prescription in the 
trained group was a major improvement in compliance. 
This major improvement is probably due to the patients’ 
feeling benefit from LTOT as it was prescribed for an 
appropriately low PaO, (668), coupled with greater under- 
standing of their need to use if for as many hours as 
possible. It is difficult from this study to decide which is the 
most important. However, subgroup analysis of the control 
group showed no difference between patients who had been 
initially assessed with blood gases and those who had not. 
This suggests an additional effect of formal education on 
compliance. It is likely however that the control group had 
received some training from the supplier as well as from 
their own doctor. 
There was a significant difference in mortality between 
both groups. Eight patients who had received formal train- 
ing died prior to completing the study as compared to 28 in 
the control group. This could have occurred for several 
reasons. The patient may be correctly prescribed LTOT, 
but may not adhering to treatment due to lack of under- 
standing. However, the LTOT may be prescribed too late 
using clinical criteria only. The patient may have been in 
respiratory failure long before obvious clinical signs, such 
as for car pulmonale, became apparent. 
It was disappointing to find that despite a formal assess- 
ment and training programme, one patient was smoking. 
Smoking was, however, significantly higher among the 
control where six patients continued to smoke, including 
one who developing facial burns as a consequence. The 
cessation of smoking remains an important prerequisite 
before starting LTOT and continued abuse is likely to have 
a significant impact on increasing mortality and reducing 
the effectiveness of therapy (12). 
Despite the presence of clear guidelines, oxygen concen- 
trators are still being inappropriately prescribed and used. 
Furthermore patients’ understanding of why they are 
receiving such therapy is often poor. The introduction of 
formal assessment and a simple training programme by a 
specialist nurse can have a significant impact both on 
appropriate prescription and compliance. More effort is 
required to ensure that those patients who may benefit from 
LTOT are referred to their local respiratory team. 
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